A Relative Bioavailability Study of Selpercatinib (LY3527723) in Healthy Participants
Clinical trial NCT05136404 · COMPLETED
Trial details
- NCT number
- NCT05136404
- Sponsor
- Loxo Oncology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-03
- Primary completion
- 2022-03-14
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.